The Role of MicroRNA in Diagnosis of Huntington's Disease: A Systematic Review.

What was studied

This review looked at microRNAs in Huntington's disease. MicroRNAs are short RNA molecules that control gene activity. They can be measured in plasma and spinal fluid. The review asked if they could track change over time. It looked at onset, progression and treatment. The search ran up to November 2024. It included 1889 participants.

What they found

Some microRNAs were repeatedly found to be dysregulated. These were miRNA-9, miRNA-124, miRNA-214, miRNA-146a and miRNA-10b. Another reported an AUC above 0.90 for a panel of several microRNAs. Methods varied a lot. Diagnostic measures were not fully reported. This limited meta-analysis.

What it means for patients

The authors say microRNAs, especially those from exosomes, may serve as minimally invasive markers. They say current evidence supports this potential. They say immediate clinical use is not yet feasible.

Why it is not certain yet

The methods differed a lot. This limited pooling of results. The authors say assay standardization and outside validation are needed. The data come from other studies. New data may change the picture. The abstract gives no pooled numbers.

Source

The Role of MicroRNA in Diagnosis of Huntington's Disease: A Systematic Review.

We restate facts from the source record in our own words. The original wording belongs to its publisher.